{
    "clinical_study": {
        "@rank": "136309", 
        "arm_group": {
            "arm_group_label": "Laser Treatment", 
            "arm_group_type": "Experimental", 
            "description": "Laser Treatment"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the safety and the efficacy of a  laser in the\n      treatment of vulvovaginal atrophy (VVA), that is to assess the change in the severity of the\n      vaginal dryness symptom, by means of a visual analogic scale (10 cm VAS)."
        }, 
        "brief_title": "Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Vulvovaginal Atrophy", 
        "condition_browse": {
            "mesh_term": "Atrophy"
        }, 
        "detailed_description": {
            "textblock": "The laser handpiece (probe) will be deposited in the vaginal canal and the laser energy will\n      be delivered through the handpiece.  Subjects will receive a total of three (3) treatments\n      every six (6) weeks (+/-1 week).  Subjects will return one week (+/- 3 days) post the first\n      treatment, as well as three (3) months (+/- 2 weeks) and twelve (12) months (+/- 2 weeks)\n      post the third treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy non-smoking post menopausal women  with absence of menstruation of at least\n             12 months\n\n          -  Exhibiting VVA symptoms\n\n          -  Prolapse staged < II, according to the pelvic organ prolapse quantification\n             (ICS-POP-Q) system\n\n          -  Have not had procedures in the anatomical area through 6 months prior to treatment\n\n          -  Understand and accept the obligation and is logistically able to present for all\n             scheduled follow-up visits\n\n        Exclusion Criteria:\n\n          -  \u2022 Acute or recurrent urinary tract infection (UTI), or genital infection (e.g. herpes\n              candida).\n\n               -  Prolapse staged \u2265 II, according to the pelvic organ prolapse quantification\n                  (ICS-POP-Q) system\n\n               -  Any serious disease, or chronic condition, that could interfere with the study\n                  compliance\n\n               -  Previously undergone reconstructive pelvic surgery\n\n               -  Have used vaginal creams, moisturizers, lubricants or homeopathic preparations\n                  for at least 3 months\n\n               -  A history of thrombophlebitis\n\n               -  A history of acute infections\n\n               -  A history of heart failure\n\n               -  Received or is anticipated to receive antiplatelets, anticoagulants,\n                  thrombolytics,   vitamin E or anti inflammatories within 2 weeks pre treatment\n\n               -  Any medical condition, that, in the investigator's opinion would interfere with\n                  the patient's participation in the study\n\n               -  Taking medications that are photosensitive\n\n               -  A history of keloid formation"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02085980", 
            "org_study_id": "ELEN13-VVA-MK01"
        }, 
        "intervention": {
            "arm_group_label": "Laser Treatment", 
            "description": "The laser handpiece (probe) will be deposited in the vaginal canal and the laser energy will be delivered through the handpiece", 
            "intervention_name": "Laser treatment", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 4, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Tine Bjornlund", 
                    "phone": "650-724-7826"
                }, 
                "facility": {
                    "address": {
                        "city": "Palo Alto", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94306"
                    }, 
                    "name": "Stanford University"
                }, 
                "investigator": {
                    "last_name": "Eric Sokol, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Kathryn Zimmerman", 
                    "phone": "513-585-0415"
                }, 
                "facility": {
                    "address": {
                        "city": "West Chester", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45069"
                    }, 
                    "name": "The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital"
                }, 
                "investigator": {
                    "last_name": "Mickey Karram, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy", 
        "overall_contact": {
            "last_name": "Kathryn Zimmerman", 
            "phone": "513-585-0415"
        }, 
        "overall_official": [
            {
                "affiliation": "Hospital Physician, The Christ Hospital", 
                "last_name": "Mickey Karram, MK", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Stanford University", 
                "last_name": "Eric Sokol, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The change in the vaginal dryness symptom will be assessed by means of a visual analogic scale (10 cm VAS).", 
            "measure": "The main outcome of the study is the efficacy of the laser procedure, intended as the amelioration of 50% of the severity of the vaginal dryness at 12 months, compared with baseline", 
            "safety_issue": "No", 
            "time_frame": "Baseline and at follow up visit at 12 months post last treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02085980"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "12037029", 
            "citation": "van der Laak JA, de Bie LM, de Leeuw H, de Wilde PC, Hanselaar AG. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry. J Clin Pathol. 2002 Jun;55(6):446-51."
        }, 
        "source": "El. En. SpA", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "The Christ Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Stanford University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "El. En. SpA", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}